Starpharma Holdings Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Starpharma Holdings Limited with three other
companies in this sector in Australia:
Oncosil Medical Ltd
sales of 3.76 million Australian Dollars [US$2.92 million]
(3.20 million Australian Dollars [US$2.49 million]
of which 100%
was Mesenchymal Precursor Cell), and
(3.87 million Australian Dollars [US$3.01 million]
of which 53%
During the year ended June of 2017, sales at
Starpharma Holdings Limited were A$3.65 million (US$2.84 million).
decrease of 21.3%
versus 2016, when the company's sales were A$4.63 million.